Moderna

Regional Account Manager, Midwest

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Regional Account Manager - Ohio

Employment Type: Full-time

Position Overview

Moderna is seeking an experienced Regional Account Manager to support the commercialization of Moderna’s groundbreaking vaccine portfolio, specifically focusing on the respiratory vaccine pipeline. This field sales role is based in Ohio, covering the entire state except for the Cincinnati/Dayton area. Reporting to a Senior Director, Regional Account Management, you will be responsible for developing and enhancing customer relationships with the largest vaccinators, including Health Systems, State Awardees/VFC, Federally Qualified Health Centers, Contracting Entities, Physician Groups, and Specialty Providers.

The successful candidate will develop expert knowledge of Moderna’s respiratory vaccine portfolio and mRNA platform, leveraging this knowledge and an understanding of strategic customer requirements to expand vaccination rates and achieve sales targets. This role requires thriving in a fast-paced, team environment and excelling at building high-level customer relationships across clinical, operational, procurement, business development, trade management, and marketing teams.

Responsibilities

  • Develop strategic account plans to enhance customer relationships, achieve sales targets, and facilitate retention and growth within key accounts (IDNs, Health Systems, FQHCs, Awardees, Physician Groups, Contracting Entities, etc.).
  • Oversee successful communication and negotiation with key accounts.
  • Serve as the primary point of contact for Moderna within the assigned territory.
  • Analyze sales trends for product sales to each account and achieve defined goals and objectives.
  • Develop expert knowledge of the company's products to ensure a thorough understanding of customer requirements.
  • Promote a mutually beneficial business relationship while adhering to Moderna Core Values and Mindsets.
  • Establish and execute tactical initiatives within channels, as directed by the Sr. Director, aligning with business unit objectives.
  • Analyze account objectives for each product and develop strategic/tactical plans to accomplish brand business objectives.
  • Develop and maintain contacts within the industry to gather marketplace, competitive, and product-specific information.
  • Build and maintain long-term relationships within the territory to ensure customer alignment and create a foundation for new business.
  • Collaborate and partner with internal and external stakeholders to enhance Moderna’s market position.
  • Cultivate close relationships with cross-functional colleagues in Medical Affairs, Marketing, Distribution/Logistics, Customer Service, and Public Affairs to implement corporate, operational, market access, and brand-specific strategies and tactics.
  • Represent Moderna at key trade and customer meetings/conferences.
  • Promote Moderna’s portfolio of products to key customers in a way that drives differentiation and successful long-term business relationships.
  • Liaise with Contracts, Customer Operations, Legal, HR, and Finance to ensure successful outcomes for the territory.

Requirements (Minimum Qualifications)

  • Bachelor’s Degree required.
  • Minimum of 10 years of experience in pharmaceutical/biotech account strategy and account management.

Qualifications (Preferred Qualifications)

  • Prior experience in vaccines is highly preferred.
  • Demonstrated prior experience in establishing and consistently meeting or exceeding business development/sales targets.
  • Experience in a startup environment, preferably launching new vaccines or medicines.
  • Experience working with complex Academic Medical Centers & teaching hospitals.
  • Working knowledge of capitated and risk-based providers and fundamentals of value-based care.
  • Demonstrated track record of building and driving volume and market share.

Skills

Sales
Account Management
Customer Relationship Management
Vaccine Portfolio Knowledge
mRNA Platform Knowledge
Strategic Account Planning
Negotiation
Sales Trend Analysis
Business Development

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI